Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
The product will be manufactured at Lupin’s facility in Goa, India.
Based on DESTINY-Lung02 results which showed AstraZeneca and Daiichi Sankyo’s Enhertu reported a confirmed objective response rate of 57.7% in patients with HER2-mutant disease
Urged stakeholders to come up with similar digital platforms and create homegrown best practices where Indian methods and Indian solutions dominate the digital spaces
The vaccine has been developed by the National Equine Research Center, Hisar (Haryana) in collaboration with the Indian Veterinary Research Institute, Izzatnagar (Bareilly)
The company has reported total income of Rs. 4138.6 crores during the period ended June 30, 2022.
The Sri Sathya Sai Sanjeevani Super Speciality Hospital in Batticaloa will begin its operations by conducting free paediatric cardiac care surgeries and interventions in the next few days
The inspection concluded with four Form 483 observations. None of the observations were related to data integrity.
Subscribe To Our Newsletter & Stay Updated
